Keywords: bioxell, takes, back, bxl746, roche, milan, italy-based

BioXell takes back BXL746 from Roche

Article | 22 January 2007

Print This

Milan, Italy-based BioXell SpA has exercised the option to acquire the novel vitamin D3 analog, BXL746, from Swiss drug major ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in